ADAM17 and triple-A syndrome: SMC- or EC-specific deletion of ADAM17 protected the aorta from elastase-induced TAA formation88, whereas ADAM17 deficiency in SMCs provided protection against AAA triggered by Ang II + BAPN treatment116.